FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220764529> ?p ?o ?g. }

• W4220764529 abstract "Abstract Purpose To report the efficacy of postoperative diclofenac eye drops for pain reduction in patients undergoing topography-guided transepithelial surface ablation. Methods Retrospective consecutive case series of patients undergoing topography-guided transepithelial surface ablation for refractive myopia treatment using a 1 KHz excimer laser. Patients were divided into three groups. Group 1 did not receive any diclofenac drops, group 2 received one diclofenac drop postoperatively (day 1), and group 3 received one drop of diclofenac postoperatively (day 1) and on the day after treatment (day 2). Postoperative pain was self-assessed by patients per eye daily for the first 4 consecutive days (days 1 to 4) after the treatment using the visual analogue scale (VAS). We compared VAS with respect to the use of additional oral or topical treatment as well as VAS with regards to the total amount of ablated tissue (< 50 µm, 50 – 100 µm, ≥ 100 µm) among the groups. Results We enrolled 163 eyes of 163 patients (55.0% female), with a mean age of 31.3 years (SD ± 6.6; range 21 – 68). We excluded 16 patients who applied other additional analgesics. Group 1 comprised 35 eyes (21%), group 2 had 21 eyes (13%), and group 3 consisted of 107 eyes (66%). Median pain score (VAS) was 5 (range 0, 10) in group 1, which was higher than in groups 2 (median 1, range 0 to 7) and 3 (median 1.5, range 0 to 7) on the day of surgery (p < 0.0001). Percentage of patients using an additional oral NSAID on days 1 and 2 was significantly higher in group 1 (69/83%) when compared to groups 2 (24/43%) or 3 (31/49%) (p < 0.001 day 1, p = 0.001 day 2). No correlation was found between pain sensation and maximum ablation depth (Spearman correlation p > 0.05). Conclusion The instillation of one drop of diclofenac after topography-guided transepithelial surface ablation reduced subjective pain sensation according to VAS and decreased the need for additional topical anesthetic drops or oral NSAID." @default.
• W4220764529 created "2022-04-03" @default.
• W4220764529 creator A5018058500 @default.
• W4220764529 creator A5022956666 @default.
• W4220764529 creator A5025646770 @default.
• W4220764529 creator A5051836847 @default.
• W4220764529 creator A5057826586 @default.
• W4220764529 creator A5087844557 @default.
• W4220764529 date "2022-03-23" @default.
• W4220764529 modified "2023-09-28" @default.
• W4220764529 title "Efficacy of Diclofenac in Pain Reduction after Topography-Guided Transepithelial Surface Ablation" @default.
• W4220764529 cites W1985554918 @default.
• W4220764529 cites W1990300362 @default.
• W4220764529 cites W2008568799 @default.
• W4220764529 cites W2031993289 @default.
• W4220764529 cites W2038967250 @default.
• W4220764529 cites W2077162912 @default.
• W4220764529 cites W2082937096 @default.
• W4220764529 cites W2102993121 @default.
• W4220764529 cites W2122769365 @default.
• W4220764529 cites W2160457820 @default.
• W4220764529 cites W2233482698 @default.
• W4220764529 cites W2586472050 @default.
• W4220764529 cites W2626021371 @default.
• W4220764529 cites W2800102560 @default.
• W4220764529 cites W2940813786 @default.
• W4220764529 cites W3045072165 @default.
• W4220764529 cites W4234596920 @default.
• W4220764529 doi "https://doi.org/10.1055/a-1739-0410" @default.
• W4220764529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35320868" @default.
• W4220764529 hasPublicationYear "2022" @default.
• W4220764529 type Work @default.
• W4220764529 citedByCount "0" @default.
• W4220764529 crossrefType "journal-article" @default.
• W4220764529 hasAuthorship W4220764529A5018058500 @default.
• W4220764529 hasAuthorship W4220764529A5022956666 @default.
• W4220764529 hasAuthorship W4220764529A5025646770 @default.
• W4220764529 hasAuthorship W4220764529A5051836847 @default.
• W4220764529 hasAuthorship W4220764529A5057826586 @default.
• W4220764529 hasAuthorship W4220764529A5087844557 @default.
• W4220764529 hasConcept C118487528 @default.
• W4220764529 hasConcept C126322002 @default.
• W4220764529 hasConcept C141071460 @default.
• W4220764529 hasConcept C14184104 @default.
• W4220764529 hasConcept C2777625524 @default.
• W4220764529 hasConcept C2778902805 @default.
• W4220764529 hasConcept C2779826273 @default.
• W4220764529 hasConcept C2780820201 @default.
• W4220764529 hasConcept C42219234 @default.
• W4220764529 hasConcept C71924100 @default.
• W4220764529 hasConceptScore W4220764529C118487528 @default.
• W4220764529 hasConceptScore W4220764529C126322002 @default.
• W4220764529 hasConceptScore W4220764529C141071460 @default.
• W4220764529 hasConceptScore W4220764529C14184104 @default.
• W4220764529 hasConceptScore W4220764529C2777625524 @default.
• W4220764529 hasConceptScore W4220764529C2778902805 @default.
• W4220764529 hasConceptScore W4220764529C2779826273 @default.
• W4220764529 hasConceptScore W4220764529C2780820201 @default.
• W4220764529 hasConceptScore W4220764529C42219234 @default.
• W4220764529 hasConceptScore W4220764529C71924100 @default.
• W4220764529 hasLocation W42207645291 @default.
• W4220764529 hasLocation W42207645292 @default.
• W4220764529 hasOpenAccess W4220764529 @default.
• W4220764529 hasPrimaryLocation W42207645291 @default.
• W4220764529 hasRelatedWork W1866720 @default.
• W4220764529 hasRelatedWork W21298218 @default.
• W4220764529 hasRelatedWork W270709 @default.
• W4220764529 hasRelatedWork W2900520 @default.
• W4220764529 hasRelatedWork W3307929 @default.
• W4220764529 hasRelatedWork W4014254 @default.
• W4220764529 hasRelatedWork W4762251 @default.
• W4220764529 hasRelatedWork W527582 @default.
• W4220764529 hasRelatedWork W844564 @default.
• W4220764529 hasRelatedWork W1717489 @default.
• W4220764529 isParatext "false" @default.
• W4220764529 isRetracted "false" @default.
• W4220764529 workType "article" @default.